ESC 365 - Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography

ESC Premium Access

Circulating galectin 1 is associated with severity of coronary artery disease and adverse cardiovascular events in patients undergoing coronary angiography

Session: Poster Session 6 - Coronary artery disease inflammation

Topic: Inflammation and Immunity

Speaker: Doctor R. Chou (Taipei, TW)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Ruey-Hsing Chou

Taipei Veterans General Hospital, Taipei (Taiwan)

0 follower

10 more presentations in this session

Inflammation implicated in the aetiology of major vascular and non-vascular diseases in East Asians

Speaker: Doctor M. Karim (Oxford, GB)

Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Speaker: Doctor D. Takagi (Kyouto, JP)

Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients

Speaker: Doctor H. Yamamoto (Kobe, JP)

Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism

Speaker: Doctor E. Kulikowski (Calgary, CA)

Access the full session

Poster Session 6 - Coronary artery disease inflammation

Speakers: Doctor R. Chou, Doctor M. Karim, Professor P. Pignatelli Spinazzola, Doctor D. Takagi, Doctor H. Yamamoto...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources